LA Improves the Prognosis of Patients With ICVD After Surgery
Ischemia; Cerebrovascular, Cognitive Impairment
About this trial
This is an interventional treatment trial for Ischemia; Cerebrovascular
Eligibility Criteria
Inclusion Criteria: 35-60 years old; Diagnosed as ischemic cerebrovascular disease, mild to moderate symptoms, can independently complete the neuropsychological test; No previous operation history; The modified Rankin scale score was 0 or 1; Carotid artery ischemic symptoms ≤3 months before treatment; Surgical treatment; Exclusion Criteria: Previous dementia; hearing or visual impairment; drugs that may or are known to affect cognitive abuse; alcohol addiction; Diagnosis of depression, schizophrenia and other mental diseases; MRI showed severe cerebral infarction; Patients with Lactobacillus acidophilus allergy.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Control group
LA treatment group
The patient received conventional care after surgery, with no other interventions.
The patient received conventional treatment and Lactobacillus acidophilus treatment for three months after surgery.